The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Treatment response and survival outcome of patients with late relapse (LR) from renal cell carcinoma (RCC) in the era of targeted therapy.
Nils Kroeger
Other Remuneration - GlaxoSmithKline; Pfizer
Jae-Lyun Lee
Honoraria - Bayer; Novartis; Pfizer
Research Funding - Bayer
Georg A. Bjarnason
Consultant or Advisory Role - Pfizer
Honoraria - Pfizer
Research Funding - Pfizer
Jennifer J. Knox
Consultant or Advisory Role - AVEO
Research Funding - Pfizer
Mary J. MacKenzie
Honoraria - Novartis; Pfizer
Ulka N. Vaishamayan
No relevant relationships to disclose
Lori Wood
Consultant or Advisory Role - GlaxoSmithKline (U); Novartis (U); Pfizer (U)
Research Funding - GlaxoSmithKline; Novartis; Pfizer
Sandy Srinivas
No relevant relationships to disclose
Sun Young Rha
Consultant or Advisory Role - GlaxoSmithKline; Novartis; Pfizer
Research Funding - Bayer; Novartis
Sumanta Kumar Pal
No relevant relationships to disclose
Takeshi Yuasa
No relevant relationships to disclose
Frede Donskov
Research Funding - Novartis
Neeraj Agarwal
Consultant or Advisory Role - Dendreon
Min-Han Tan
No relevant relationships to disclose
Aristotelis Bamias
Consultant or Advisory Role - Novartis; Pfizer; Roche
Honoraria - Bayer; GlaxoSmithKline; Novartis; Roche
Christian K. Kollmannsberger
Consultant or Advisory Role - GlaxoSmithKline; Novartis; Pfizer
Honoraria - GlaxoSmithKline; Novartis; Pfizer
Scott A. North
Consultant or Advisory Role - Bayer; GlaxoSmithKline; Novartis; Pfizer
Brian I. Rini
Consultant or Advisory Role - AVEO; Bayer; GlaxoSmithKline; Onyx; Pfizer
Research Funding - GlaxoSmithKline; Pfizer
Toni K. Choueiri
Consultant or Advisory Role - AVEO; Bayer; Genentech; GlaxoSmithKline; Novartis; Onyx; Pfizer
Research Funding - Pfizer
Daniel Yick Chin Heng
Consultant or Advisory Role - AVEO; Bayer; Novartis; Pfizer